detoxification · Mechanism Report
Does the GSTP1 rs1695 AG genotype alter glutathione-conjugation activity?
The GSTP1 rs1695 AG genotype produces the Ile105Val enzyme variant and can change glutathione-conjugation activity in a substrate-dependent way.
This is what AI claimed
The GSTP1 rs1695 AG genotype changes the Ile105Val enzyme and can alter glutathione-conjugation activity in a substrate-dependent manner.
Executive summary
This claim says the AG genotype encodes a GSTP1 Ile105/Val105 heterozygous enzyme state rather than a single uniform protein form. The mechanism is framed as a structural change in the enzyme’s substrate-binding region, which can shift conjugation activity and stability depending on the substrate involved. It does not imply the same direction of effect for all compounds.
Verified conclusion
GSTP1 rs1695 is a common coding variant with a well-established biochemical consequence: the AG genotype encodes the Ile105/Val105 heterozygous state. Its relevance is enzymatic rather than a uniform prediction of detoxification capacity or clinical outcome.
Molecular and functional evidence
- rs1695 is c.313A>G: the A allele encodes Ile105 and the G allele Val105. Thus, AG carriers are expected to express both Ile105- and Val105-containing GSTP1 subunits.
- Purified recombinant allozymes show altered glutathione-conjugation kinetics, including substrate affinity, turnover, and catalytic efficiency. In human lung cytosol, CDNB-conjugating activity in Ile/Val individuals was intermediate (62.1 ± 4.2 nmol·mg⁻¹·min⁻¹) between reported Ile/Ile and Val/Val activity.
Substrate-specific mechanism
- Ile105Val remodels the enzyme’s hydrophobic substrate-binding H-site, altering pocket geometry, hydrophobicity, and steric accommodation. The glutathione-binding G-site is not the principal affected region.
- With CDNB, Val105-containing enzyme had a higher Km than Ile105 (1.15 vs 0.33 mM in Ala114-background proteins), consistent with lower apparent substrate affinity and reduced catalytic efficiency.
- This is not a universal loss of function: Val105 can show greater activity toward ethacrynic acid and substantially greater efficiency toward some polycyclic-aromatic-hydrocarbon diol epoxides.
Additional biochemical consideration
- Val105-containing GSTP1 is reported to be approximately two- to threefold less thermally stable than the Ile105 form, which could further influence enzyme performance under particular experimental or cellular conditions.
Bottom line
- The claim is supported: rs1695 AG produces the GSTP1 Ile105/Val105 variant state, and the substitution can alter glutathione conjugation. Its effect is substrate-dependent—potentially lower for some electrophiles and higher for others—so AG should not be interpreted as globally reduced or increased GSTP1 function.
References
- NM_000852.4(GSTP1):c.313A>G (p.Ile105Val) AND fluorouracil ... — ncbi.nlm.nih.gov
- Evaluating the role of GSTP1 genetic polymorphism (rs1695 ... — pmc.ncbi.nlm.nih.gov
- Carcinogenesis vol.19 no.2 pp.275–280, 1998 — citeseerx.ist.psu.edu
- Variants of glutathione s-transferase pi 1 exhibit differential ... — pmc.ncbi.nlm.nih.gov
- Structure-activity relationships and thermal stability of ... — pubmed.ncbi.nlm.nih.gov
- GSTP1 Ile105Val (rs1695) — GeneOps — geneops.ai
- Gene Sequence Variation and Functional Genomic Studies — pmc.ncbi.nlm.nih.gov
- The Role of Glutathione S-transferase P in signaling pathways and ... — pmc.ncbi.nlm.nih.gov
See a full patient report verified like this
Book a walkthrough